Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

BACKGROUND: There is little information about the efficacy of active alternative drugs to carbapenems except β-lactam/β-lactamase inhibitors for the treatment of bloodstream infections (BSIs) due to extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-E). The objective of this study was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Principais autores: Palacios-Baena, Zaira Raquel, Gutiérrez-Gutiérrez, Belén, Calbo, Esther, Almirante, Benito, Viale, Pierluigi, Oliver, Antonio, Pintado, Vicente, Gasch, Oriol, Martínez-Martínez, Luis, Pitout, Johann, Akova, Murat, Peña, Carmen, Molina Gil-Bermejo, José, Hernández, Alicia, Venditti, Mario, Prim, Nuria, Bou, German, Tacconelli, Evelina, Tumbarello, Mario, Hamprecht, Axel, Giamarellou, Helen, Almela, Manel, Pérez, Federico, Schwaber, Mitchell J, Bermejo, Joaquín, Lowman, Warren, Hsueh, Po-Ren, Paño-Pardo, José Ramón, Torre-Cisneros, Julián, Souli, Maria, Bonomo, Robert A, Carmeli, Yehuda, Paterson, David L, Pascual, Álvaro, Rodríguez-Baño, Jesús
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849995/
https://ncbi.nlm.nih.gov/pubmed/29020250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix606
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados